American Healthcare REIT, Inc. $AHR Shares Sold by Westpac Banking Corp

Westpac Banking Corp lowered its holdings in American Healthcare REIT, Inc. (NYSE:AHR) by 20.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,651 shares of the company’s stock after selling 11,577 shares during the period. Westpac Banking Corp’s holdings in American Healthcare REIT were worth $1,677,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in AHR. Invesco Ltd. boosted its position in American Healthcare REIT by 1,543.1% during the 1st quarter. Invesco Ltd. now owns 5,022,455 shares of the company’s stock worth $152,180,000 after purchasing an additional 4,716,792 shares during the period. Alliancebernstein L.P. grew its stake in shares of American Healthcare REIT by 350.7% in the first quarter. Alliancebernstein L.P. now owns 4,559,365 shares of the company’s stock valued at $138,149,000 after buying an additional 3,547,635 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of American Healthcare REIT by 22.4% in the first quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock valued at $569,494,000 after buying an additional 3,437,861 shares in the last quarter. Nuveen LLC purchased a new stake in shares of American Healthcare REIT during the 1st quarter valued at about $68,097,000. Finally, Geode Capital Management LLC lifted its position in American Healthcare REIT by 20.5% during the 2nd quarter. Geode Capital Management LLC now owns 4,578,867 shares of the company’s stock worth $174,882,000 after acquiring an additional 779,109 shares in the last quarter. Institutional investors and hedge funds own 16.68% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on AHR shares. Scotiabank upped their target price on shares of American Healthcare REIT from $47.00 to $55.00 and gave the company a “sector outperform” rating in a research note on Thursday. Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a research report on Friday, October 17th. UBS Group began coverage on American Healthcare REIT in a research report on Friday, September 19th. They set a “buy” rating and a $51.00 target price on the stock. KeyCorp boosted their target price on shares of American Healthcare REIT from $43.00 to $55.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of American Healthcare REIT in a report on Wednesday, September 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, American Healthcare REIT has an average rating of “Buy” and a consensus price target of $49.40.

Insider Activity

In other American Healthcare REIT news, Director Jeffrey T. Hanson sold 20,010 shares of American Healthcare REIT stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $49.68, for a total value of $994,096.80. Following the completion of the sale, the director directly owned 21,798 shares in the company, valued at $1,082,924.64. The trade was a 47.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the transaction, the executive vice president owned 59,100 shares in the company, valued at $2,475,699. This represents a 6.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 25,360 shares of company stock worth $1,229,398. Insiders own 1.00% of the company’s stock.

American Healthcare REIT Price Performance

NYSE:AHR traded up $0.15 during midday trading on Monday, hitting $48.47. 115,048 shares of the stock were exchanged, compared to its average volume of 1,606,700. The business has a 50-day moving average price of $43.58 and a two-hundred day moving average price of $39.50. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $8.58 billion, a price-to-earnings ratio of 345.14, a P/E/G ratio of 2.38 and a beta of 0.98. American Healthcare REIT, Inc. has a one year low of $26.40 and a one year high of $50.51.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio is 714.29%.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.